LicianPro

Vivos Therapeutics, Inc. ·

VVOS 8-K 2026-10-01

Vivos Therapeutics, Inc. (VVOS) 8-K dated 2026-10-01 — accession 0001493152-26-045193.

Vivos Therapeutics, Inc. (VVOS) is a medical devices company listed on NASDAQ.

Vivos Therapeutics, Inc. filed a 8-K on 2026-10-01. Accession 0001493152-26-045193.

This 8-K covers: Auditor change (Item 4.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VVOS revenue for 2025-12-31 was $17.4M. Net income was -$21.2M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VVOS currently screens at market cap $7.1M.

Not investment advice. The VVOS SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr